Reply to: "Incorporating AFP-L3 and DCP in selecting patients with hepatocellular carcinoma for liver transplantation: What are the optimal criteria?"
- PMID: 38154740
- DOI: 10.1016/j.jhep.2023.12.017
Reply to: "Incorporating AFP-L3 and DCP in selecting patients with hepatocellular carcinoma for liver transplantation: What are the optimal criteria?"
Comment on
-
Incorporating AFP-L3 and DCP in selecting patients with hepatocellular carcinoma for liver transplantation: What are the optimal criteria?J Hepatol. 2024 Apr;80(4):e171-e172. doi: 10.1016/j.jhep.2023.09.034. Epub 2023 Oct 10. J Hepatol. 2024. PMID: 37821020 No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
